Lv41
488 积分 2022-03-10 加入
A selective HDAC8 inhibitor potentiates antitumor immunity and efficacy of immune checkpoint blockade in hepatocellular carcinoma
17小时前
已完结
A researcher’s guide to preclinical mouse NASH models
21天前
已完结
Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma
1个月前
已完结
Molecular mechanisms in MASLD/MASH-related HCC
1个月前
已完结
Metabolic dysfunction-associated steatotic liver disease and its link to cancer
1个月前
已完结
Estimated Burden of Metabolic Dysfunction–Associated Steatotic Liver Disease in US Adults, 2020 to 2050
1个月前
已完结
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002–2033: the ITA.LI.CA database
1个月前
已完结
An updated overview on hepatocellular carcinoma in patients with Metabolic dysfunction-Associated Steatotic Liver Disease: Trends, pathophysiology and risk-based surveillance
1个月前
已完结
Cholesterol’s new tricks propel MASH-HCC: impact in immunotherapy
1个月前
已完结
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
1个月前
已完结
皖公网安备34019202002308
